Oxytocin Ban: Case to have far-reaching effects on Public Health Rights, SC refers matter to larger BenchAugust 25 2019
Can private companies produce the Oxytocin drug for domestic use in India?
On Thursday, a Division Bench of the Supreme Court held that the question raises serious issues having far-reaching implications and referred it to a three-judge Bench. The order passed by a Bench of Justices AM Sapre and Indu Malhotra states,
"... this is a fit case to refer the matter to a larger Bench of three Judges to consider the aforesaid . . .
This content is restricted to subscribers
With a premium account you get:
- One year of unrestrcited access to previous interviews, columns and articles
- One year access to all archival material
- Access to all Bar & Bench reports